Personalized wellness app program for improving health
Aspire2B Personalization Pilot Study Program
NA · PepsiCo Global R&D · NCT06191822
This study is testing a new wellness app that helps people improve their health through nutrition, fitness, and sleep challenges while trying to see if it can lower their biological age.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 3000 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | PepsiCo Global R&D (industry) |
| Locations | 1 site (Chicago, Illinois) |
| Trial ID | NCT06191822 on ClinicalTrials.gov |
What this trial studies
The Aspire2B Personalization Pilot Study Program evaluates the functionality of a mobile wellness application designed to predict physiological states and biological age through non-invasive measurements. Participants engage in nutrition, fitness, or sleep challenges within the app to enhance their overall wellness and potentially lower their biological age. This non-randomized pilot study focuses on integrating behavioral theory, user feedback, and practical feasibility to assess the app's effectiveness. The program is conducted remotely by PepsiCo clinical researchers, allowing for broad participation without the need for facility visits.
Who should consider this trial
Good fit: Ideal candidates are smartphone users fluent in English or Spanish who are interested in improving their health through a mobile app.
Not a fit: Patients who are not smartphone users or those who cannot download and use the app will not benefit from this study.
Why it matters
Potential benefit: If successful, this program could help individuals improve their health and wellness through personalized interventions.
How similar studies have performed: While mobile health interventions have shown promise in improving wellness, this specific approach using the Aspire2B app is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Fluent in reading and understanding English or Spanish * Smartphone users Exclusion Criteria: * Cannot proceed to onboarding without downloading the app, consenting to participate, and agreeing to app Terms of Use
Where this trial is running
Chicago, Illinois
- Remote, no facility visits. Managed by PepsiCo R&D Life Sciences — Chicago, Illinois, United States (RECRUITING)
Study contacts
- Principal investigator: Tristin Brisbois, PhD, MBS — PepsiCo Global R&D
- Study coordinator: Shellen Goltz, PhD, RD
- Email: Shellen.Goltz@pepsico.com
- Phone: 312-821-3317
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: App Proficiency, Behavior, Lifestyle, Biological age, Wellness app